Literature DB >> 1821258

Hippocampal abnormalities in depression.

K R Krishnan1, P M Doraiswamy, G S Figiel, M M Husain, S A Shah, C Na, O B Boyko, W M McDonald, C B Nemeroff, E H Ellinwood.   

Abstract

A quantitative magnetic resonance imaging study of regional brain T1 spin-lattice relaxation times in 29 normal volunteers and in 20 patients with major depression revealed significantly shortened T1 relaxation times for the hippocampus in depressed patients. These differences were particularly prominent in elderly depressed patients. T1 relaxation times are reflective of the content and macromolecular environment of tissue water protons; shorter hippocampal T1 values may reflect differences in the content or organizational properties of hippocampal water protons. These findings are consistent with several lines of evidence that have implicated a role for the hippocampus in the regulation of mood and in the pathophysiology of the stress response, and they suggest that major depression may be associated with biophysical tissue changes in the aging hippocampus.

Entities:  

Mesh:

Year:  1991        PMID: 1821258     DOI: 10.1176/jnp.3.4.387

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  19 in total

1.  Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure.

Authors:  P J Lucassen; M B Müller; F Holsboer; J Bauer; A Holtrop; J Wouda; W J Hoogendijk; E R De Kloet; D F Swaab
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

2.  MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder.

Authors:  J D Bremner; P Randall; T M Scott; R A Bronen; J P Seibyl; S M Southwick; R C Delaney; G McCarthy; D S Charney; R B Innis
Journal:  Am J Psychiatry       Date:  1995-07       Impact factor: 18.112

3.  Cellular changes in the postmortem hippocampus in major depression.

Authors:  Craig A Stockmeier; Gouri J Mahajan; Lisa C Konick; James C Overholser; George J Jurjus; Herbert Y Meltzer; Harry B M Uylings; Lee Friedman; Grazyna Rajkowska
Journal:  Biol Psychiatry       Date:  2004-11-01       Impact factor: 13.382

Review 4.  Questioning the link between PTSD and cognitive dysfunction.

Authors:  Angela Danckwerts; Janet Leathem
Journal:  Neuropsychol Rev       Date:  2003-12       Impact factor: 7.444

5.  Left-right asymmetric and smaller right habenula volume in major depressive disorder on high-resolution 7-T magnetic resonance imaging.

Authors:  Seo-Eun Cho; Chan-A Park; Kyoung-Sae Na; ChiHye Chung; Hyo-Jin Ma; Chang-Ki Kang; Seung-Gul Kang
Journal:  PLoS One       Date:  2021-08-03       Impact factor: 3.240

Review 6.  Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.

Authors:  Jonathan Savitz; Wayne C Drevets
Journal:  Neurosci Biobehav Rev       Date:  2009-01-21       Impact factor: 8.989

7.  Differential autoreceptor control of extracellular 5-HT in guinea pig and rat: species and regional differences.

Authors:  Zoë A Hughes; Lee A Dawson
Journal:  Psychopharmacology (Berl)       Date:  2003-09-30       Impact factor: 4.530

8.  Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression.

Authors:  J Douglas Bremner; Meena Vythilingam; Chin K Ng; Eric Vermetten; Ahsan Nazeer; Dan A Oren; Robert M Berman; Dennis S Charney
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

9.  APOE related hippocampal shape alteration in geriatric depression.

Authors:  Anqi Qiu; Warren D Taylor; Zheen Zhao; James R MacFall; Michael I Miller; Cynthia R Key; Martha E Payne; David C Steffens; K Ranga R Krishnan
Journal:  Neuroimage       Date:  2008-10-28       Impact factor: 6.556

10.  Hippocampal atrophy in recurrent major depression.

Authors:  Y I Sheline; P W Wang; M H Gado; J G Csernansky; M W Vannier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.